Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RORC | P51449 | 2/20 | 0.34 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | GPR183 | P32249 | 1/20 | 0.31 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.31 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.31 |
| ▸ | JAK2 | O60674 | 1/20 | 0.31 |
| ▸ | JAK1 | P23458 | 1/20 | 0.31 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.30 |
| ▸ | EGLN2 | Q96KS0 | 1/20 | 0.30 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.30 |
| ▸ | SCD5 | Q86SK9 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30898144 | 0.92 | RORC (0.38) | RORCGPR119USP2SMN1; SMN2GPR183 | |
| SCHEMBL30898023 | 0.91 | RORC (0.38) | RORCUSP2SMN1; SMN2GPR183CYP11B2 | |
| SCHEMBL30898045 | 0.90 | SCD5 (0.36) | RORCGPR119USP2SMN1; SMN2GPR183 | |
| SCHEMBL30898215 | 0.90 | GPR183 (0.37) | RORCUSP2SMN1; SMN2GPR183CYP11B2 | |
| SCHEMBL30898235 | 0.89 | SCD5 (0.38) | RORCGPR119USP2GPR183CYP11B2 | |
| SCHEMBL30898090 | 0.87 | CYP11B2 (0.39) | RORCGPR119USP2GPR183CYP11B2 | |
| SCHEMBL30898219 | 0.86 | CYP2D6 (0.38) | RORCGPR119USP2SMN1; SMN2CYP11B2 | |
| SCHEMBL30898190 | 0.85 | — | — | |
| SCHEMBL30898060 | 0.85 | — | — | |
| SCHEMBL30898156 | 0.84 | CYP2D6 (0.41) | GPR119USP2SMN1; SMN2CYP11B2EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024083086-A1 | BICYCLIC DERIVATIVE INTEGRIN INHIBITOR | 上海如凌生物医药有限公司 | 2024-04-25 | — | — | WO | disclosed |
| CN-117903171-A | Integrin inhibitors of a class of bicyclic derivatives | 上海如凌生物医药有限公司 | 2024-04-19 | — | — | CN | disclosed |